Affimed Nv Stock Performance
AFMD Stock | USD 5.00 0.15 2.91% |
The firm shows a Beta (market volatility) of 1.1, which signifies a somewhat significant risk relative to the market. Affimed NV returns are very sensitive to returns on the market. As the market goes up or down, Affimed NV is expected to follow. Affimed NV has an expected return of -0.07%. Please make sure to confirm Affimed NV potential upside, day median price, and the relationship between the total risk alpha and accumulation distribution , to decide if Affimed NV performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Affimed NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound primary indicators, Affimed NV is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
Actual Historical Performance (%)
One Day Return (2.72) | Five Day Return (5.11) | Year To Date Return (19.84) | Ten Year Return (91.21) | All Time Return (91.21) |
Last Split Factor 1:10 | Last Split Date 2024-03-11 |
1 | Affimed announces 1-for-10 reverse stock split | 03/06/2024 |
2 | ASTR Stock Alert Astra Space Is Going Private | 03/08/2024 |
3 | Affimed Short Interest Update | 03/12/2024 |
4 | Affimed N.V., Hutchmed, Annexon among healthcare movers | 03/14/2024 |
5 | Affimed To Report Full Year 2023 Financial Results Corporate Update on March 28, 2024 | 03/21/2024 |
6 | AFMD Stock Earnings Affimed Beats EPS, Misses Revenue for Q4 2023 | 03/28/2024 |
7 | Earnings call Affimed reports progress in clinical trials and financial stability | 04/01/2024 |
8 | Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK Cell Therapy Candidate in Lupus Nephritis | 04/17/2024 |
Begin Period Cash Flow | 190.3 M |
Affimed |
Affimed NV Relative Risk vs. Return Landscape
If you would invest 571.00 in Affimed NV on January 24, 2024 and sell it today you would lose (71.00) from holding Affimed NV or give up 12.43% of portfolio value over 90 days. Affimed NV is currently does not generate positive expected returns and assumes 5.4445% risk (volatility on return distribution) over the 90 days horizon. In different words, 48% of stocks are less volatile than Affimed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
Risk |
Affimed NV Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Affimed NV's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Affimed NV, and traders can use it to determine the average amount a Affimed NV's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0129
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | AFMD |
Estimated Market Risk
5.44 actual daily | 48 52% of assets are more volatile |
Expected Return
-0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Affimed NV is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Affimed NV by adding Affimed NV to a well-diversified portfolio.
Affimed NV Fundamentals Growth
Affimed Stock prices reflect investors' perceptions of the future prospects and financial health of Affimed NV, and Affimed NV fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Affimed Stock performance.
Return On Equity | -1.01 | ||||
Return On Asset | -0.43 | ||||
Operating Margin | (3.82) % | ||||
Current Valuation | 59.24 M | ||||
Shares Outstanding | 15.23 M | ||||
Price To Earning | (2.04) X | ||||
Price To Book | 1.41 X | ||||
Price To Sales | 6.29 X | ||||
Revenue | 8.28 M | ||||
Gross Profit | 42.87 M | ||||
EBITDA | (103.81 M) | ||||
Net Income | (105.94 M) | ||||
Cash And Equivalents | 237.23 M | ||||
Cash Per Share | 1.59 X | ||||
Total Debt | 19.35 M | ||||
Debt To Equity | 0.1 % | ||||
Current Ratio | 4.90 X | ||||
Book Value Per Share | 3.85 X | ||||
Cash Flow From Operations | (110.27 M) | ||||
Earnings Per Share | (7.56) X | ||||
Market Capitalization | 78.42 M | ||||
Total Asset | 97.16 M | ||||
Retained Earnings | (536.13 M) | ||||
Working Capital | 58.28 M | ||||
Current Asset | 78.33 M | ||||
Current Liabilities | 8.94 M | ||||
About Affimed NV Performance
To evaluate Affimed NV Stock as a possible investment, you need to clearly understand its upside potential, downside risk, and overall future performance outlook. You may be satisfied when Affimed NV generates a 15% return over the last few months, but what if the market is generating 25% over the same period? In this case, it makes sense to compare Affimed Stock's performance with different market indexes, such as the Dow or NASDAQ Composite. These indexes can act as benchmarks that will help you to understand Affimed NV market performance in a much more refined way. The Macroaxis performance score is an integer between 0 and 100 that represents Affimed's market performance from a risk-adjusted return perspective. Generally speaking, the higher the score, the better is overall performance as compared to other investors. The score is normalized against the average investing universe (the best we can interpret from the data available). Within this methodology, scores of individual equity instruments will always be inferior to the scores of portfolios of equities as portfolios typically diversify a lot of unsystematic risks away. The formula to derive the Macroaxis score bases on multiple unequally-weighted factors. For more information, refer to our portfolio performance evaluation section.
Please also refer to our technical analysis and fundamental analysis pages.Last Reported | Projected for Next Year | ||
Days Of Inventory On Hand | 0.00 | 0.00 | |
Return On Tangible Assets | (1.09) | (1.15) | |
Return On Capital Employed | (1.50) | (1.42) | |
Return On Assets | (1.09) | (1.14) | |
Return On Equity | (1.83) | (1.74) |
Things to note about Affimed NV performance evaluation
Checking the ongoing alerts about Affimed NV for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Affimed NV help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.Affimed NV generated a negative expected return over the last 90 days | |
Affimed NV has high historical volatility and very poor performance | |
Affimed NV has a very high chance of going through financial distress in the upcoming years | |
The company reported the previous year's revenue of 8.28 M. Net Loss for the year was (105.94 M) with profit before overhead, payroll, taxes, and interest of 42.87 M. | |
Affimed NV currently holds about 237.23 M in cash with (110.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.59. | |
Affimed NV has a frail financial position based on the latest SEC disclosures | |
Latest headline from finance.yahoo.com: Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK Cell Therapy Candidate in Lupus Nephritis |
- Analyzing Affimed NV's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Affimed NV's stock is overvalued or undervalued compared to its peers.
- Examining Affimed NV's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Affimed NV's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Affimed NV's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Affimed NV's stock. These opinions can provide insight into Affimed NV's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Affimed NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. For information on how to trade Affimed Stock refer to our How to Trade Affimed Stock guide.You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for Affimed Stock analysis
When running Affimed NV's price analysis, check to measure Affimed NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Affimed NV is operating at the current time. Most of Affimed NV's value examination focuses on studying past and present price action to predict the probability of Affimed NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Affimed NV's price. Additionally, you may evaluate how the addition of Affimed NV to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Stocks Directory Find actively traded stocks across global markets | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |
Is Affimed NV's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Affimed NV. If investors know Affimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Affimed NV listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (7.56) | Revenue Per Share 0.931 | Quarterly Revenue Growth (0.58) | Return On Assets (0.43) | Return On Equity (1.01) |
The market value of Affimed NV is measured differently than its book value, which is the value of Affimed that is recorded on the company's balance sheet. Investors also form their own opinion of Affimed NV's value that differs from its market value or its book value, called intrinsic value, which is Affimed NV's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Affimed NV's market value can be influenced by many factors that don't directly affect Affimed NV's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Affimed NV's value and its price as these two are different measures arrived at by different means. Investors typically determine if Affimed NV is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Affimed NV's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.